Raloxifene (Evista) Research in Pennsylvania | QSC
QSC RESEARCH GRADE — PENNSYLVANIA
≥99% HPLC PurityMS ConfirmedJanoshik COADomestic USA Shipping
Raloxifene (Evista) Research — Pennsylvania
Raloxifene (Evista) is a Selective Oestrogen Receptor Modulator (SERM) — second-generation used in research models studying Breast Cancer Prevention Research, Osteoporosis / Bone Density Research, Gynecomastia Research. QSC supplies Raloxifene to research institutions, university laboratories, and independent researchers across Pennsylvania with domestic USA shipping and third-party Janoshik COA verification.
About Raloxifene (Evista)
Raloxifene is a benzothiophene SERM with distinct tissue-selective ER modulation profile compared to tamoxifen. Acts as ER antagonist in breast and uterus — critically, without the partial uterine agonism seen with tamoxifen (no endometrial proliferation risk). Acts as ER agonist in bone (preserves BMD) and lipid metabolism (reduces LDL). This superior tissue selectivity profile makes raloxifene u…
QSC operates a domestic USA fulfilment network with 5-region shipping coverage. Orders to Pennsylvania ship from the nearest domestic hub — typically 3–5 business days. All compounds ship in sealed, temperature-appropriate, discrete packaging with Janoshik COA documentation.
